FINHUB Insights

SYK · Q2 FY25 · Apr 1 – Jun 30, 2025

Stryker Q2 FY25: where the revenue came from and where it went

Stryker Q2 FY25: revenue $6B (+11% year over year). Net profit $0.9B. Largest cohort Med Surg and Neurotechnology $3.8B. The whole income statement as a sankey diagram from the SEC filing.

Period
Apr 1 – Jun 30, 2025
Reported
Aug 1, 2025 10-Q
Sankey diagram of Stryker's income statement for Q2 FY25: revenue of $6 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$6B +11% year over year
Gross profit$3.8B 64% margin
Operating profit$1.1B 18% margin
Net profit$0.9B 15% margin

The numbers

All figures in billions of U.S. dollars, for Q2 FY25 (period ends Jun 30, 2025).
ItemValueShare of revenueYear over year
Revenue 6 100% +11%
Med Surg and Neurotechnology 3.8 63% +17%
Orthopaedics and Spine 2.3 38% +2%
Cost of revenue−2.237%
Gross profit3.864% margin+1pp
Research & development−0.47%+0pp
SG&A−2.135%+1pp
Other−0.24%+0pp
Operating profit1.118% margin−1pp
Tax−0.1
Interest & other costs−0.1
Net profit0.915%−1pp
Filing on EDGAR More quarters of SYK

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

Older quarters